摘要
目的观察石氏颈髓通络方治疗脊髓型颈椎病的临床疗效。方法将60例病例随机分为治疗组和对照组(各30例),治疗组予石氏颈髓通络方加减口服,对照组予甲钴胺口服;两组均治疗8周,分别于治疗前及治疗后第4周、第8周末进行症状体征评分,试验结束后判定临床疗效。结果治疗组、对照组总有效率分别为84.00%、57.14%,组间临床疗效差异有统计学意义(P<0.05)。治疗组在第4周、第8周末症状体征积分均高于对照组(P<0.05)。结论石氏颈髓通络方治疗脊髓型颈椎病疗效良好。
Objective To observe the clinical efficacy of Shi＇ s ＂Jingsui Tongluo Prescrition＂ in treating cervical spnodylotic myelopathy. Methods Sixty cases were randomized into treatment group and control group. Thirty cases in treatment group were treated with modified ＂Jingsui Tongluo Prescrition＂ orally, and thirty cases in control group were treated with mecobalamin orally, with the course of 8 weeks. Symptoms and physical signs were tested at the end of fourth week and the eighth week after treatment .respectively. The clinical efficacy was investigated after test. Results The total effective rate was 84.00% in treatment group and 57. 14% in control group, with a difference between the two groups （ P 〈 0.05 ） ; the symptom score was higher in treatment group than in the control group at the fourth week and eighth week （ P 〈0.05 ）. Conclusion Shi＇ s ＂Jingsui Tongluo Prescrition＂ has positive effect on cervical spnodylotic myelopathy.
出处
《上海中医药杂志》
2012年第1期49-51,共3页
Shanghai Journal of Traditional Chinese Medicine
关键词
脊髓型颈椎病
中医药疗法
石氏颈髓通络方
cervical spnodylotic myelopathy
Chinese medicine
＂Jingsui Tongluo Prescrition＂
